Home
Contact
Sitemap
Newsletter
Organization
EUCAST statutes
Steering Committee
General Committee
Subcommittees
Phage subcommittee
Antifungal Susceptibility Testing
Antimycobacterial AST
MIC distributions and ECOFFs
WGS and Phenotypic testing
VetCAST
National AST Committees (NAC)
Development Laboratories
Network Laboratories
Public consultations
EUCAST News
Definitions of S, I and R
Clinical breakpoints and dosing
About "Clinical breakpoints".
Rationale documents
Splitting MIC wild type distributions
When there are no breakpoints?
Breakpoints in brackets
EUCAST setting breakpoints.
Rapid AST in blood cultures
Calibration files
RAST from EUCAST in publications
Methods
QC
Breakpoints for short incubation
Screening for resistance mechanisms with RAST
FAQ on RAST
Expert rules and expected phenotypes
Expected phenotypes
Resistance mechanisms
Guidance documents
SOP
MIC and zone distributions and ECOFFs
New and revised ECOFFs
AST of bacteria
IVDR
Media preparation
MIC determination
Disk diffusion methodology
Disk diffusion implementation
Breakpoint tables
Quality Control
Strains with defined susceptibility
S. pneumoniae
P. aeruginosa
Calibration and validation
Warnings!
MIC testing services from EUCAST
Previous versions of documents
AST of mycobacteria
AMST organisation
Clinical breakpoints for antimycobacterial agents
MIC & ECOFFs
Methods in Mycobacteria
FAQ Mycobacteria
RDs
Scientific publications
Meetings & Minutes
AST of fungi
Breakpoints for antifungals
MIC distributions and ECOFFs
Methods in antifungal susceptibility testing
AST of yeasts
AST of moulds
AST of dermatophytes
QC AFST Tables
Rationale documents for antifungals
Documents for discussion in AFST
Publications in journals
Meetings, Minutes and Reports
Previous versions of documents
AST of veterinary pathogens
VetCAST rationale documents
VetCAST meetings
AST of phages
Frequently Asked Questions (FAQ)
Meetings
EUCAST meetings
Rationale documents and publications
Rationale Documents
Consultations
Publications in journals
Technical notes
Posters
External documents
Reports
Presentations and statistics
Videos and online seminars
Online seminars
Seminar links
English
Chinese
Warnings!
Translations
EUCAST in Serbian
Information for industry
Links and Contacts
EUCAST Contact form
Rationale documents and publications
Organization
Public consultations
EUCAST News
Definitions of S, I and R
Clinical breakpoints and dosing
Rapid AST in blood cultures
Expert rules and expected phenotypes
Resistance mechanisms
Guidance documents
SOP
MIC and zone distributions and ECOFFs
AST of bacteria
AST of mycobacteria
AST of fungi
AST of veterinary pathogens
AST of phages
Frequently Asked Questions (FAQ)
Meetings
Rationale documents and publications
Rationale Documents
Consultations
Publications in journals
Technical notes
Posters
External documents
Reports
Presentations and statistics
Videos and online seminars
Warnings!
Translations
Information for industry
Links and Contacts
Website changes
EUCAST posters at ECCMID Copenhagen 2023
New CLSI and EUCAST harmonized procedure for selecting
optimal disk contents for disk diffusion testing
EUCAST disk diffusion testing of anaerobic bacteria –
Expanding the range of antimicrobial agents
Corynebacterium diphtheriae and C. ulcerans –
Development of clinical breakpoints using EUCAST methodology
Toxigenic and non-toxigenic Vibrio cholerae can share the
same MIC breakpoints.
Robust statistical tool for defining antimicrobial inhibition
zone diameter wild-type distributions and calculating ECOFFs
QUICK NAVIGATION
Organization
EUCAST statutes
Steering Committee
General Committee
Subcommittees
...... Phage susceptibility testing
...... Antifungal Susceptibility Testing
...... Antimycobacterial susceptibility testing (AMST)
...... MIC and zone diameter distributions and ECOFFs
...... Relationship between WGS and phenotypic AST.
...... Veterinary susceptibility testing (VetCAST)
National AST Committees (NAC)
EUCAST Development Laboratories
EUCAST Network Laboratories
Public consultations
EUCAST News
S, I and R definitions
Clinical breakpoints and dosing of antibiotics
About "Clinical breakpoints".
The rationale behind clinical breakpoints
Splitting wild type distributions.
When there are no breakpoints?
Breakpoints in brackets
EUCAST setting breakpoints.
Rapid AST in bloodcultures
Calibration files
RAST from EUCAST in publications
Methods
QC
Breakpoints for short incubation
Screening for R-mechanisms
FAQ on RAST
Expert rules and expected phenotypes
Expected phenotypes
Resistance mechanisms
Guidance Documents
SOPs
MIC and zone distributions and ECOFFs
New and revised ECOFFs
AST of bacteria
IVDR
Media preparation
MIC determination
Disk diffusion methodology
Disk diffusion implementation
Breakpoint tables
Quality Control
Strains with defined susceptibility
...... S. pneumoniae
...... P. aeruginosa
Calibration and validation
Warnings!
EUCAST MIC-testing services
Previous versions of documents
AST of mycobacteria
Organisation of AMST
Clinical breakpoints for antimycobacterial agents
MIC distributions and ECOFFs for mycobectaria
Methodology for AST in Mycobacteria
FAQ Mycobacteria
Rationale documents
Publications in journals
Meetings and minutes
AST of fungi
Breakpoints for antifungals
MIC distributions and ECOFFs
Methods in AFST
...... AST of yeasts
...... AST of moulds
...... AST of dermatophytes
QC AFST Tables
Rationale documents for antifungals
Documents for discussion
Publications in journals
Meetings, Minutes and Reports
Previous versions of documents
Veterinary Susceptibility Testing
Rationale documents for VetCAST breakpoints
VetCAST meetings
AST of phages
Frequently Asked Questions (FAQ)
Meetings
EUCAST meetings
Rationale documents and publications
Rationale Documents
Public consultations
Publications in journals
Technical notes
Posters
External documents
Reports
Presentations and statistics
Videos and online seminars
Online seminars
Online seminar links
English
Chinese
WARNINGS!
Translations
EUCAST in Serbian
Information for industry
Links and Contacts
EUCAST Contact form
TOP
